Stability Testing Software

AmpleLogic Stability is a GAMP 5 validated stability testing and schedule management platform designed for pharmaceutical, biotech, API, CDMO, and generic drug organisations. It covers the full lifecycle of stability studies — from protocol creation and schedule planning through chamber monitoring, test execution, trend analysis, shelf-life determination, and regulatory reporting — within a single integrated LIMS environment aligned to ICH Q1A, FDA 21 CFR Part 211.166, and GMP requirements.

The platform addresses common pain points in manual stability management, including missed sample pulls, inconsistent protocol formats, disconnected environmental data, delayed trend analysis, and fragmented audit trails. It replaces spreadsheet-based tracking and paper logs with an automated, centralised workflow intended to reduce manual effort and support continuous audit readiness.

Core Workflow Steps

1. Define Stability Test Protocol: Create ICH Q1A-compliant protocols using configurable templates that specify storage conditions, time points, acceptance criteria, packaging configurations, and automated sampling schedules.
2. Build Stability Schedule Calendar: Auto-generate a visual calendar showing pull dates, chamber assignments, analyst allocations, and automated reminders across all active studies.
3. Monitor Chamber Conditions: Real-time temperature and humidity monitoring with sensor integration, automated excursion alerts, and environmental data linked directly to study records.
4. Execute and Capture Results: Run analytical tests within the LIMS workflow using direct instrument connectivity, in-line calculations, and full sample-to-result traceability.
5. Analyse Trends and Determine Shelf-Life: AI-powered trend analysis with degradation modelling, statistical shelf-life projection, expiry determination, and confidence interval reporting.
6. Generate Regulatory Reports: Produce ICH-compliant stability reports, FDA submission packages, and GMP documentation automatically from study data.

Platform Capabilities

• Unified Study Dashboard: Single view of all active, completed, and planned stability studies with real-time status, upcoming pull dates, and overdue alerts across products and conditions.
• Stability Schedule Management Engine: Automated pull scheduling, dynamic rescheduling, priority-based queue management, and calendar-based views for every study.
• Interactive Trend Analytics: Multi-batch overlay charts, degradation curve fitting, out-of-trend and out-of-specification detection, and predictive shelf-life forecasting from a single analytics console.
• Complete Audit Trail: Timestamped, user-identified, ALCOA+-compliant records covering every action from protocol creation through result entry and report generation.
• Smart Notification Centre: Configurable alerts for upcoming pulls, overdue tests, OOT results, chamber excursions, and protocol deviations, with multi-level escalation workflows.
• Cross-System Integration: Bi-directional integration with LIMS, ERP, QMS, and instrument systems to maintain a single source of truth for stability data.

Regulatory Compliance Coverage

• FDA 21 CFR Part 11 and Part 211.166
• EU GMP Annex 11
• GAMP 5
• ICH Q1A (R2), Q1B, Q1C, Q1D, Q1E, and Q5C
• Data Integrity (ALCOA+)
• WHO Technical Report Series
• MHRA

Reported Performance Metrics

• 40% faster study setup
• 30% reduction in missed sample pulls
• 60% less manual tracking effort
• 50% cost savings
• 100% ICH compliance alignment

AmpleLogic Stability is deployed within a 3–6 month timeframe and is positioned as a module within the broader AmpleLogic LIMS solution. It serves organisations across pharmaceutical R&D, biotech and biologics, API manufacturing, CDMO/CMO operations, generic drug companies, and nutraceuticals.